Monografie
Elucidating the effect of anti-VEGF-A and anti-ANG-2 in combination with immunecheckpoint inhibition targeted treatment in small cell lung cancer
- Sprache
-
Englisch
- Identifier
-
1315571374
Thema
Krebs; Immuntherapie; Tumorwachstum; Tiermodell; T-Lymphozyt; Lungenkrebs
Beteiligte Personen und Organisationen
Otto, Christoph
Ullrich, Roland
Niessen, Carien
Ullrich, Roland
Niessen, Carien
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.02.2024, 11:10 MEZ
Objekttyp
- Monografie
Beteiligte
- Otto, Christoph
- Ullrich, Roland
- Niessen, Carien
Ähnliche Objekte (12)
EpCAM CAR T cells for the treatment of lung cancer brain metastasis - an in vivo imaging study in the mouse
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Regulatory T Cells and Maternal Immune Tolerance in Pregnancy Associated Breast Cancer - a Murine Model
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Role of p21 in CD4+ T cells in the antitumor response against colorectal cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity
Enhancing CHM1319 specific TCR-transgenic T cell cytotoxic effect on Ewing sarcoma cell lines
EpCAM CAR T cells for the treatment of lung cancer brain metastasis - an in vivo imaging study in the mouse
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Regulatory T Cells and Maternal Immune Tolerance in Pregnancy Associated Breast Cancer - a Murine Model
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Role of p21 in CD4+ T cells in the antitumor response against colorectal cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity
Enhancing CHM1319 specific TCR-transgenic T cell cytotoxic effect on Ewing sarcoma cell lines
EpCAM CAR T cells for the treatment of lung cancer brain metastasis - an in vivo imaging study in the mouse
Characterizing the tumor microenvironment upon transcutaneous immunization by single-cell RNA-sequencing - implications for cancer immunotherapy
Establishment of a human CD22-transgenic lymphoma mouse model to study immunotherapies in organ-specific tumor microenvironments
Frequency, phenotype and clinical relevance of dendritic cells and T cells in colorectal cancer and pancreatic ductal adenocarcinoma and their therapeutic modulation
Endogenous antigen-specific T and B cell immune responses in cancer and invasive infections are frequent, but often limited by potentially targetable immune escape mechanisms
A screening for novel immune-checkpoints identifies CAMK1D as a kinase responsible for immune resistance in multiple myeloma
Einfluss von CD25+ regulatorischen T-Zellen auf die therapeutische Effektivität tumorspezifischer T-Zellen nach LRAST (Lymphodepletion, Rekonstitution und aktiv-spezifischer Tumortherapie) in einem murinen Melanom-Modell
Regulatory T Cells and Maternal Immune Tolerance in Pregnancy Associated Breast Cancer - a Murine Model
Tumor-infiltrating lymphocytes as biomarkers to monitor local ablation of primary and secondary liver cancer
Role of p21 in CD4+ T cells in the antitumor response against colorectal cancer
Metabolic engineering of murine cytotoxic T cells by solute carrier Slc2a1/GLUT1 overexpression to enhance anti-tumor activity